Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence.

Kotak, Sohny; Khatri, Mahima; Malik, Mehreen; Malik, Maria; Hassan, Warda; Amjad, Arooba; Malik, Farheen; Hassan, Hani; Ahmed, Jawad; Zafar, Marium

Kotak, Sohny; Khatri, Mahima; Malik, Mehreen; Malik, Maria; Hassan, Warda; Amjad, Arooba; Malik, Farheen; Hassan, Hani; Ahmed, Jawad; Zafar, Marium.

Afiliación

Kotak S; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Khatri M; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Malik M; Anesthesiology, Aga Khan University, Karachi, PAK.
Malik M; Anesthesiology, Indus Hospital, Lahore, PAK.
Hassan W; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Amjad A; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Malik F; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Hassan H; Internal Medicine, Karachi Medical and Dental College, Karachi, PAK.
Ahmed J; Internal Medicine, Dow University of Health Sciences, Karachi, PAK.
Zafar M; Internal Medicine, Dow Medical College, Karachi, PAK.

Cureus ; 12(10): e10869, 2020 Oct 09.

Article en En | MEDLINE | ID: mdl-33178522

Palabras clave

coronavirus disease; covid-19; efficacy; interleukin-6; meta-analysis; mortality; safety; sars-cov-2; systematic review; tocilizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_geracao_evidencia_conhecimento / 4_covid_19 Tipo de estudio: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Cureus Año: 2020 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google